Foundayo™ (orforglipron) is a once-daily oral GLP-1 receptor agonist developed for the management of obesity and weight-related health conditions. It belongs to a modern class of medications that help regulate appetite, reduce food intake, and support clinically significant weight loss—without the need for injections.

Designed as a convenient tablet, Foundayo offers an innovative alternative to injectable GLP-1 therapies, making long-term weight management simpler and more accessible.

Key Benefits of Foundayo (Orforglipron)

• 💊 Once-daily oral tablet – no injections required
• ⚖️ Supports clinically proven weight loss
• 🍽️ Helps reduce appetite and cravings
• 🩺 May improve blood sugar, cholesterol, and blood pressure
• 🕒 Flexible dosing with no meal-time restrictions
• 🔬 Advanced GLP-1 receptor agonist mechanism

How Foundayo Works

Foundayo mimics the natural hormone GLP-1 (glucagon-like peptide-1), which:

• Increases feelings of fullness
• Slows gastric emptying
• Helps regulate appetite and calorie intake
• Supports metabolic health and weight reduction

Clinical Overview

In clinical studies, orforglipron has demonstrated:

• Significant body weight reduction (up to ~11–12%)
• Improved cardiometabolic markers
• Favorable tolerability consistent with GLP-1 class therapies

How to Use

• Take once daily as prescribed
• Can be taken with or without food
• Dose is typically increased gradually under medical supervision

Possible Side Effects

Common side effects may include:

• Nausea
• Diarrhea or constipation
• Vomiting
• Reduced appetite

Most effects are mild to moderate and often improve over time.

Important Information

Foundayo (orforglipron) is a prescription medication. It should only be used under the supervision of a qualified healthcare professional as part of a comprehensive weight management plan including diet and physical activity.